Federal cannabis prohibition stifles research despite high usage rates in Michigan and beyond

Indigenous and traditional knowledge systems have long recognized cannabis’s medicinal and spiritual properties, often integrating it into holistic healing practices. However, federal prohibition has systematically erased these perspectives, replacing them with Western biomedical frameworks that prioritize synthetic compounds over plant-based remedies. The lack of research funding for indigenous-led studies further entrenches this knowledge gap, despite centuries of empirical use in communities like the Rastafari or Native American herbalists.

Cannabis prohibition in the U.S. traces back to racist campaigns in the early 20th century, including Harry Anslinger’s demonization of Mexican immigrants and Black jazz musicians. The 1937 Marihuana Tax Act and later the Controlled Substances Act (1970) were shaped by economic protectionism for timber and synthetic fiber industries, not public health. Michigan’s 2008 medical legalization and 2018 adult-use legalization reflect a broader trend of state-level defiance of federal policy, echoing Prohibition-era alcohol laws.

Globally, cannabis has been used medicinally and spiritually for millennia, from Ayurvedic traditions in India to Sufi practices in Central Asia. In Jamaica, cannabis is central to Rastafarian spirituality and traditional medicine, yet its criminalization reflects colonial imposition of Western drug laws. Meanwhile, in Morocco, cannabis cultivation has sustained rural economies for centuries, despite international pressure to eradicate it—a parallel to Michigan’s post-industrial reliance on cannabis as a revenue source.

Federal prohibition has created a research bottleneck, with the DEA’s monopoly on cannabis cultivation licenses limiting studies to low-potency strains. The NIH’s funding priorities skew toward synthetic cannabinoids or harm reduction, ignoring whole-plant synergy and terpene interactions documented in traditional medicine. Meanwhile, state-level legalization has enabled observational studies (e.g., Michigan’s tracking of dispensary sales), but federal barriers prevent large-scale clinical trials or epidemiological research.

Cannabis has been a muse for artists, musicians, and spiritual seekers across cultures, from Bob Marley’s Rastafarian hymns to the Beat Generation’s explorations of consciousness. In Western art, its prohibition has paradoxically fueled countercultural movements that challenge authoritarian control over bodily autonomy. However, the spiritual dimensions of cannabis use are often reduced to stereotypes (e.g., 'stoner culture') in mainstream narratives, erasing its role in meditation, creativity, and communal healing practices.

If federal rescheduling occurs, Michigan could become a model for integrating cannabis research into public health systems, particularly for chronic pain and PTSD. However, without addressing structural inequities in research access, marginalized communities may remain excluded from clinical trials or economic benefits. Future scenarios include a bifurcated system where states legalize while federal restrictions persist, or a corporate takeover of cannabis research, sidelining traditional and small-scale producers.

Black and Latino communities in Michigan bear the brunt of cannabis prohibition, facing disproportionate arrests despite similar usage rates to white populations. Indigenous and low-income patients are often denied access to medical cannabis due to cost barriers or lack of dispensaries in rural areas. Meanwhile, women-led cannabis businesses and LGBTQ+ entrepreneurs face systemic discrimination in licensing and funding, despite driving innovation in the industry.